Ayala Pharmaceuticals Inc (ADXS)

[williamjay]

James, I agree with you. Just like this deal was unexpected, I think you could see multiple deals like this one going forward. Advaxis will be plug and play for other IO platforms as an adjunct to improve efficacy and extend existing patent protections. if you recall, LifeSci disclosed in its most recent analysis that it expects to receive investment banking fees from Advaxis during the first quarter of 2017. I am curious to see if that comes to pass as part of a deal with a major BP. In addition, I expect a deal for HOT and infectious diseases this year. Plus, NEO's IND is expected to be filed early 2017. I expect a nice milestone payment when that happens. Then, we still have all the study updates , canine osteo approval, EU submission plus who knows what in terms of deals like this one that were not factored in at all.